Praj Industries Limited has been bestowed the Bio Excellence Award 2012 in the BioIndustrial category at the Bangalore India Bio. The award was presented at the hands of Dr. T. Ramasamy, Secretary of the DBT. This award was given to Praj for the hard work and efforts of Praj Matrix- the innovation center towards research in bioindustrials. Praj was also awarded with Bio Excellence Award in the 2009. Innovation... 

Oxitec Ltd, a British company pioneering a new approach to combating dengue fever, announced today that it has secured GBP8 million of new investment. The investment will finance further trials of the Oxitec Control Programme, designed to reduce populations of the dengue mosquito in communities hardest hit by the disease. The Oxitec solution harnesses advanced genetics to create ‘sterile’... 

The enterprise times assists enterprise service providers with free reach solutions, free publicity, and free search engine optimization services. With today’s business communication age, paced towards the World Wide Web and services being sought out through search engines, there is a growing need for business organizations and enterprises for promoting themselves widely through the World Wide Web. There... 

The enterprise http://www.theenterprisetimes.net/index.php/category/technology-news-2 http://www.theenterprisetimes.net/index.php/category/the-enterprise-news http://www.theenterprisetimes.net/index.php/category/business-consulting http://www.theenterprisetimes.net/index.php/category/the-enterprise-news/business-news-enterprise-news http://www.theenterprisetimes.net/index.php/category/b-to-b-2/business-management/enterprise-solutions/enterprise-it http://www.theenterprisetimes.net/index.php/category/b-to-b-2/business-management/enterprise-solutions http://www.theenterprisetimes.net/index.php/category/b-to-b-2/business-management/enterprise-solutions/enterprise-it/services-it/erp-services-it http://www.theenterprisetimes.net/index.php/category/technology-news-2 http://www.theenterprisetimes.net/index.php/category/the-enterprise-news-headlines http://www.theenterprisetimes.net/index.php/category/the-enterprise-news-top-stories http://www.theenterprisetimes.net/index.php/category/biotechnology-2 http://www.theenterprisetimes.net/index.php/category/communications   Enterprise... 

The Enterprise Times has a specific coverage on the trends and analysis on the business and business of enterprise in india, aspects that affect Indian business.News related to business in india,business news on india.There are various external and internal factors that affect the business scenario in india and the larger aspects of the Enterprise in India.  Read More →

The Enterprise Times coverage of the Enterprise revolves around the business enterprise ,the global business environment,on business with india,latest business news. On the INDUSTRY SECTORS like Automobile,manufacturing,Packaging,Banks,IT and Banking, IT industry, Consulting, IT Consulting, Information technology,Business and technology, oil industry, food industry, construction industry, fashion industry,... 

Aveo Pharmaceuticals Inc., manufacturer of an experimental medicine for kidney cancer, fails to attract the investors for having “ultra high expectations” but still Aveo is planning to expand in preparation for approval of the medicine, called tivozanib. The drug helps patients with advanced renal cell carcinoma live for 11.9 months without their disease progressing in a late-stage study, compared... 

Janssen Biotech, one of the Janssen Pharmaceutical Companies has entered into an agreement with Johnson & Johnson in Pharmacyclics, a prominent area in the research domain who will jointly develop and market the anti-cancer compound, PCI-32765. A number of phase I and II studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle... 

Mylan launches generic version of Cyklokapron injection   Mylan has announced that its business Mylan Institutional has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tranexamic Acid Injection, 100 mg/mL, packaged in 1,000 mg/10 mL single-dose vials. This product is the generic version of Pharmacia & Upjohn’s... 

Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals and the global leader in scientific information, has announced that it has received a grant from The Michael J Fox Foundation for Parkinson’s Research (MJFF) to create and publish the world’s most comprehensive source of biological maps for Parkinson’s disease (PD). The project aims... 

Prakruthik Health Care (PHCPL), the first India Nano-technology based Preventive Health Care Company has launched its first product,  En-Tube capsules, the best solution for intra-corporeal detoxification through nano-technology En-Tube, indeed has been a well researched formulation of highly purified, Nano Svarijika, a mineral and Platago Ovata Husk, a herb. These ingredients are an Ayurvedic Composition... 

RxMD Founded in 2000,is a strategic execution group providing clinical development expertise to the biotech and pharmaceutical community. Managed and operated by physician-scientists, RxMD has, over the years, played critical roles in drug development programs of leading global pharmaceutical companies. It has contributed to the development of several drug candidates and helped bring five drugs to... 

Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (US FDA) has granted final approval for its Amlodipine / Benazepril 5mg/40mg, and 10mg/40mg capsules.  Commercial shipments of the product have already commenced.  This approval completes the product line as the Company was granted final approval for Amlodipine / Benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg... 

The Drugs Controller General (India)’s South Zone Office, Chennai and Sub-zonal office, Hyderabad has conducted investigations in the matter of recent reports about certain irregularities in conduct of clinical study by M/s Axis Clinicals Ltd., Hyderabad in violation of the norms specified in Schedule Y of the Drugs and Cosmetics Rules. The investigations have revealed various irregularities... 

Jubilant Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and AstraZeneca, today announced another successful delivery of an early stage milestone in the Pain therapeutic area. The collaboration, initiated two years ago in the Neuroscience therapeutic area, has now expanded to Cardiovascular and Metabolic diseases and focuses on the delivery of a steady stream of preclinical...